Orchid Pharma1107.20
+25.40 (+2.35%)

Orchid Pharma Share Price

1107.20+25.40 (+2.35%)
+40.43% past 1 Year

Corporate filings & documents

Announcements

Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
8 hours ago
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
8 hours ago
Investor roadshow scheduled to be held in Mumbai
1 day ago
Investor roadshow scheduled to be held in Mumbai
1 day ago
Annual Report of the Company for FY 2025-26.
2 weeks ago
Annual Report of the Company for FY 2025-26.
2 weeks ago
Business Responsibility and Sustainability Report for FY 2025-26
2 weeks ago
Business Responsibility and Sustainability Report for FY 2025-26
2 weeks ago
Notice of 33rd Annual General Meeting of the Company
2 weeks ago
Appointment of cost auditor for FY 2026-27 and change in designation of director.
2 weeks ago
Appointment of cost auditor for FY 2026-27 and change in designation of director.
2 weeks ago
Outcome of Board meeting.
2 weeks ago
Outcome of Board meeting.
2 weeks ago
Transcript of Analysts/Investors earning call held with public at large on August 21 2026.
4 weeks ago
Transcript of Analysts/Investors earning call held with public at large on August 21 2026.
4 weeks ago
Audio Recording of the Analyst/Investor Earning Call for Q-1 ended on June 30 2026
1 month ago
Audio Recording of the Analyst/Investor Earning Call for Q-1 ended on June 30 2026
1 month ago
Investors Presentation-Quarter 1 of F.Y.2026-27 ended on June 30 2026.
1 month ago
Investors Presentation-Quarter 1 of F.Y.2026-27 ended on June 30 2026.
1 month ago
Intimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30 2026.
1 month ago
Intimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30 2026.
1 month ago
Statement of Deviation or variation for the quarter ended June 30 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.
1 month ago
Statement of Deviation or variation for the quarter ended June 30 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.
1 month ago
Monitoring Agency Report for Quarter-1 of F.Y. 2026-27 ended June 30 2026.
1 month ago
Monitoring Agency Report for Quarter-1 of F.Y. 2026-27 ended June 30 2026.
1 month ago
Revised Audited financial results for the Financial year ended March 31 2026 pursuant to Scheme of Merger
1 month ago
Revised Audited financial results for the Financial year ended March 31 2026 pursuant to Scheme of Merger
1 month ago
Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
1 month ago
Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
1 month ago
Outcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
1 month ago
Outcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30 2026.
1 month ago
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Limited reviewed financial result (standalone and consolidated) of the company for Quarter-1 ended on June 30 2026 and restated Audited (Standalone & Consolidated) Financial Results for the Quarter and Financial Year ended March 31 2026 on account of scheme of Amalgamation coming into effect
1 month ago
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Limited reviewed financial result (standalone and consolidated) of the company for Quarter-1 ended on June 30 2026 and restated Audited (Standalone & Consolidated) Financial Results for the Quarter and Financial Year ended March 31 2026 on account of scheme of Amalgamation coming into effect
1 month ago
Intimation under regulation 30- Update on scheme of Amalgamation
1 month ago
Intimation under regulation 30- Update on scheme of Amalgamation
1 month ago
Outcome of Board Meeting held on August 01 2026
1 month ago
Outcome of Board Meeting held on August 01 2026
1 month ago
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 inter alia to consider and approve Prior intimation of Board Meeting scheduled to be held on August 01 2026
1 month ago
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 inter alia to consider and approve Prior intimation of Board Meeting scheduled to be held on August 01 2026
1 month ago
Intimation regarding Investor Roadshow
1 month ago
Intimation regarding Investor Roadshow
1 month ago
Confirmation certificate under Regulation 74(5) of Securities and Exchange board of India (Depositories and Participants) Regulations 2018.
2 months ago
Confirmation certificate under Regulation 74(5) of Securities and Exchange board of India (Depositories and Participants) Regulations 2018.
2 months ago
Fixation of Record Date pursuant to scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited for alloting shares to Shareholders of Dhanuka Laboratories Limited
2 months ago
Fixation of Record Date pursuant to scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited for alloting shares to Shareholders of Dhanuka Laboratories Limited
2 months ago
Outcome of Board Meeting: Amendment in the Capital Clause of Memorandum of Association of Company pursuant to the effectiveness of Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited.
2 months ago
Outcome of Board Meeting: Amendment in the Capital Clause of Memorandum of Association of Company pursuant to the effectiveness of Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited.
2 months ago
Outcome of the Board Meeting
2 months ago
Outcome of the Board Meeting
2 months ago
Update related to the Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Amalgamated Company/Company") and their respective Shareholders and Creditors ("the Scheme") under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015("SEBI Listing Regulations") as amended.
2 months ago

Concalls & investor presentations

Aug 2026
ConcallPresentation
Aug 2026
May 2026
ConcallPresentation
May 2026
Feb 2026
ConcallPresentation
Feb 2026
May 2025
Aug 2024
ConcallPresentation
Aug 2024
May 2024
ConcallPresentation
May 2024
Feb 2024
ConcallPresentation
Feb 2024
Nov 2023
ConcallPresentation
Nov 2023
Aug 2023
ConcallPresentation
Aug 2023
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
May 2022
Feb 2022
ConcallPresentation
May 2021

Orchid Pharma Ltd Share Price Today

The Orchid Pharma Ltd share price today is ₹947.90. During the trading session, the Orchid Pharma Ltd share price opened at ₹949.90 and recorded an intraday high of ₹955.15 and a low of ₹944.10. Last closing price was ₹954.65. Over the past 52 weeks, the Orchid Pharma Ltd share price has ranged between ₹480.00 and ₹1133.00. The current Orchid Pharma Ltd stock price reflects real-time market activity based on executed trades on the exchange.